The LCKD reduced glycemia, body weight and serum triglycerides in type 2 diabetic patients but close medical supervision was required to adjust diabetic and blood pressure medications.
Month: September 2015
A Low-carbohydrate, Ketogenic Diet to Treat Type 2 Diabetes
In a study of overweight individuals with type 2 diabetes, the LCKD (low carbohydrate ketogenic diet) improved glycemic control in patients with type 2 diabetes such that diabetes medications were discontinued or reduced in most participants. Other results include: mean body weight decreased by 6.6% and fasting serum triglyceride decreased 42%.
Effects of Two Weight-loss Diets on Health-related Quality of Life.
Mental aspects of HRQOL (health related quality of life) improved more in participants following an LCKD (low calorie ketogenic diet) than an LFD (low fat diet), possibly resulting from the LCKD’s composition, lack of explicit energy restriction, higher levels of satiety or metabolic effects. The factors analyzed were: Physical Functioning, Role-Physical, General Health, Vitality, Social Functioning. The Physical Component Summary score improved similarly in both diet groups. Bodily Pain improved in the LFD group only, whereas the Role-Emotional and Mental Health subscales and the Mental Component Summary (MCS) score improved in the LCKD group only.
A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss.
Obese and overweight outpatients were assigned to either a low-carbohydrate ketogenic diet (LCKD) or Orlistat therapy combined with a low fat diet (O + LFD). In a sample of medical outpatients, an LCKD led to similar improvements as O + LFD for weight, serum lipid, and glycemic parameters and was more effective for lowering blood pressure.
Fasting Lipoprotein and Postprandial Triacylglycerol Responses to a Low-carbohydrate Diet Supplemented With n-3 Fatty Acids
A hypocaloric low-carbohydrate diet rich in MUFA and supplemented with n-3 fatty acids significantly reduced postabsorptive and postprandial TG in men that were not hypertriglyceridemic as a group before the diet. This may be viewed as a clinically significant positive adaptation in terms of cardiovascular risk status.
Clinical Experience of a Carbohydrate-Restricted Diet: Effect on Diabetes Mellitus
Low carbohydrate diets lead to a marked improvement in glucose homeostasis in association with a reduction in antidiabetic therapy and weight loss.
Body Composition and Hormonal Responses to a Carbohydrate-restricted Diet
Authors conclude that a carbohydrate-restricted diet resulted in a significant reduction in fat mass and a concomitant increase in lean body mass in normal-weight men, which may be partially mediated by the reduction in circulating insulin concentrations.
Very-low-carbohydrate Weight-loss Diets Revisited
This review demonstrates that much scientific and anecdotal data demonstrate favorable metabolic responses to very-low-carbohydrate diets.
An Isoenergetic Very Low Carbohydrate Diet Improves Serum HDL Cholesterol and Triacylglycerol Concentrations, the Total Cholesterol to HDL Cholesterol Ratio and Postprandial Pipemic Responses Compared
In normal weight, normolipidemic women, a short-term very low carbohydrate diet modestly increased LDL-C, yet there were favorable effects on cardiovascular disease risk status by virtue of a relatively larger increase in HDL-C and a decrease in fasting and postprandial triaclyglycerols.
Comparison of a Very Low-Carbohydrate and Low-Fat Diet on Fasting Lipids, LDL Subclasses, Insulin Resistance, and Postprandial Lipemic Responses in Overweight Women
Compared to a low-fat weight loss diet, a short-term very low-carbohydrate diet did not lower LDL-C but did prevent the decline in HDL-C and resulted in improved insulin sensitivity in overweight and obese, but otherwise healthy women. Small decreases in body mass improved postprandial lipemia, and therefore cardiovascular risk, independent of diet composition.